Barriers to healthcare access in patients with chronic pain or potential migraine in Japan: a cross-sectional internet survey

Purpose Chronic pain and migraines often go untreated despite patient- and economic-related burdens (e.g., impaired quality of life and productivity). Understanding the reasons for non-treatment is important to enable interventions aimed at improving care-seeking behaviors. However, reports on disease-specific justifications for nontreatment in Japan are limited. We aimed to determine the barriers to healthcare access in untreated patients with chronic pain or migraines. Patients and methods This was a non-interventional, cross-sectional, internet questionnaire survey of patients with chronic pain or migraines. The primary endpoint was to identify the reasons for untreated chronic pain or migraines. Secondary endpoints included factors associated with healthcare access, including patient background, patient-reported outcomes, and awareness of generic or authorized generic drugs (AG). Results We surveyed 1,089 patients with chronic pain [605 (55.6%) untreated] and 932 patients with migraines [695 (74.6%) untreated] in 2021. The main reasons for not seeking treatment for chronic pain was “my pain is tolerable” and for migraine, “I can manage my pain with over-the-counter drugs.” Background factors significantly associated with untreated chronic pain were younger age, less time required to access the nearest medical institution, less pain, higher activities of daily living (ADL) scores, and lower awareness of generic drugs and AG. Among patients with migraine, notable characteristics included being female, having shorter travel times to the nearest medical facility, residing in municipalities with populations under 50,000, experiencing moderate to severe pain, having higher ADL scores, and displaying lower awareness of AG. The AG awareness rate was 2-fold higher in treated patients than in untreated patients. Conclusion Educating patients regarding the risks associated with pain and its underlying causes, availability of inexpensive treatment options, and location of appropriate treatment facilities may increase treatment rates.

[1]  H. Igarashi,et al.  A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan , 2022, The Journal of Headache and Pain.

[2]  Osahiko Tsuji,et al.  Internet survey on factors associated with care-seeking behaviours of people with chronic musculoskeletal pain in Japan , 2021, Journal of orthopaedic surgery.

[3]  B. Jenkins Migraine management , 2020, Australian prescriber.

[4]  K. Matsudaira,et al.  The Economic Burden of Lost Productivity due to Presenteeism Caused by Health Conditions Among Workers in Japan , 2020, Journal of occupational and environmental medicine.

[5]  A. Woolf,et al.  Global health policy in the 21st century: Challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions , 2020, Best Practice & Research Clinical Rheumatology.

[6]  T. Steiner,et al.  Migraine: a major debilitating chronic non-communicable disease in Brazil, evidence from two national surveys , 2019, The Journal of Headache and Pain.

[7]  Congo,et al.  Adolescents , 2019, Handbook of Sexuality-Related Measures.

[8]  T. Treuer,et al.  Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme , 2019, The Journal of Headache and Pain.

[9]  Erin Breitenbach,et al.  Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study , 2018, Human Resources for Health.

[10]  Theo Vos,et al.  Migraine is first cause of disability in under 50s: will health politicians now take notice? , 2018, The Journal of Headache and Pain.

[11]  T. Yamashita,et al.  The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population , 2017, European journal of pain.

[12]  J. Vietri,et al.  The relationship between pain severity and patient-reported outcomes among patients with chronic low back pain in Japan , 2016, Journal of pain research.

[13]  T. Ikemoto,et al.  Chronic Pain in the Japanese Community—Prevalence, Characteristics and Impact on Quality of Life , 2015, PloS one.

[14]  H. Ishikawa,et al.  Comprehensive health literacy in Japan is lower than in Europe: a validated Japanese-language assessment of health literacy , 2015, BMC Public Health.

[15]  A. Söderlund,et al.  What is the role of lifestyle behaviour change associated with non-communicable disease risk in managing musculoskeletal health conditions with special reference to chronic pain? , 2015, BMC Musculoskeletal Disorders.

[16]  Y. Toyama,et al.  Investigation of chronic musculoskeletal pain (third report): with special reference to the importance of neuropathic pain and psychogenic pain , 2014, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[17]  A. Lake,et al.  Clinical Aspects of Medication Overuse Headaches , 2014, Headache.

[18]  Y. Toyama,et al.  Prevalence and characteristics of chronic musculoskeletal pain in Japan , 2011, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[19]  J. Carrillo,et al.  Defining and Targeting Health Care Access Barriers , 2011, Journal of health care for the poor and underserved.

[20]  C. Hewitt,et al.  Do women consult more than men? A review of gender and consultation for back pain and headache , 2011, Journal of health services research & policy.

[21]  R. Lipton,et al.  Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS) , 2011, Cephalalgia : an international journal of headache.

[22]  N. Cornally,et al.  Help-seeking behaviour for the treatment of chronic pain. , 2011, British journal of community nursing.

[23]  R. Baron,et al.  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain , 2006, Current medical research and opinion.

[24]  Ron Z. Goetzel,et al.  Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers , 2004, Journal of occupational and environmental medicine.

[25]  R. Lipton,et al.  Lost productive time and cost due to common pain conditions in the US workforce. , 2003, JAMA.

[26]  R. Lipton,et al.  The Family Impact of Migraine: Population-Based Studies in the USA and UK , 2003, Cephalalgia : an international journal of headache.

[27]  H. Diener,et al.  Medication overuse headaches – what is new? , 2002, Expert opinion on drug safety.

[28]  R. Lipton,et al.  Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers , 2000, Pain.

[29]  R. Lipton,et al.  Reliability of the Migraine Disability Assessment Score in A Population-Based Sample of Headache Sufferers , 1999, Cephalalgia : an international journal of headache.

[30]  F Sakai,et al.  Prevalence of Migraine in Japan , 1997, Cephalalgia : an international journal of headache.

[31]  A. Zbrozek,et al.  The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument , 1993, PharmacoEconomics.

[32]  M. Dibonaventura,et al.  The societal burden of chronic pain in Japan: an internet survey , 2015, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[33]  A. Adelstein National statistics. , 1975, Postgraduate medical journal.